Dr. David L. Abramson, MD

Dr. Abramson practices at Patient Care Associates in Englewood, New Jersey.

Dr. Abramson's NPI, 1720046139, was assigned on May 3, 2006. Dr. Abramson graduated from New York University School of Medicine in 1988. Dr. Abramson's New York license number on file is 179986.

Dr. Abramson's primary practice is Patient Care Associates, at 500 Grand Avenue, Englewood, NJ 07631. The practice phone is (201) 567-8090.

Dr. Abramson's primary practice is Patient Care Associates in Englewood, New Jersey. Dr. Abramson is also affiliated with Englewood Hospital. Dmand AI also links Dr. Abramson to 1 more hospital and 2 physician offices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abramson practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Abramson's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Abramson is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Abramson's licenses on file in 5 states: New York, New Jersey, Florida, Colorado and Massachusetts.

Dmand AI lists breast reconstruction, cancerous skin growth removal and head wound among the conditions Dr. Abramson treats.

CMS data shows 57 Medicare services from Dr. Abramson across 4 procedure codes in 2024, for 79 Medicare patients. Medicare paid $6,572 for them. Every service was in an office.

CMS counts 79 Medicare patients who saw Dr. Abramson in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abramson's median patient age at 58, with 63% women.

In 2024, Dr. Abramson wrote 62 Medicare Part D claims for 40 patients. 95% of them were for generic drugs. CMS names the drug for 39 of them, across 2 drugs with 11 or more claims each, at $209 in total drug cost. In 2023, CMS named 40 claims across 2 drugs.

Dr. Abramson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of melanoma (skin cancer) excision by Dr. Abramson, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Abramson, published from 2012 to 2024. The most frequent topics are COVID-19, Cyclonic Storms and Delivery of Health Care. Dr. Abramson's most frequent co-authors are Gady Har-El, FACS, MD, Hasan F. Hashmi, MD and Alan Matarasso, MD.

Dmand AI links Dr. Abramson to 1 clinical trial.

CMS Open Payments shows 49 general payments to Dr. Abramson from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 36% of the total. TELA Bio, Inc. paid the most, $1,472. It also lists 1 research payment totaling $13,210 in 2025.

Dmand AI lists 8 awards for Dr. Abramson, most recently CMS Stage 1 2012 in 2011. Dr. Abramson serves on Member at Large New Jersey Society of Plastic Surgeons-Board of Directors and Vice President Secretary Treasurer Parlimentarian New York Regional Society of Plastic Surgeons-Board of Directors.

Dr. Abramson graduated from New York University School of Medicine in 1988. Dr. Abramson is a member of ASPS.

Dr. Abramson is in network with 7 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.